Skip to content
Review Open access

RNA m6A methylation writers in autoimmune diseases: structure, function, and therapeutic opportunities

Jul 2026 · Acta Pharmacologica Sinica · Vol 47, pp. 2777 - 2790 · 1 citation · 144 references
Medicine

TL;DR

This review focuses on the roles and mechanisms of writer‑mediated m6A modification in various immune cells but also summarizes its pharmacological modulators, which represents a key advantage over previous reviews.

Read PDF

Similar papers

Review Open access Sep 2026

The role and clinical impact of aberrant m6A RNA modification in cancer

This review systematically dissects how dysregulated m6A methylation fuels malignant transformation and progression by reinforcing core oncogenic hallmarks, sustained proliferation, metastasis, metabolic rewiring, and resistance to programmed cell death.

Sheng-Jie Tang, Rangping Xie, Jiang Fu et al. · 0 citations
Review Sep 2026

m(6)A RNA Methylation in aging and age-related diseases.

Despite advances in prevention and treatment, aging and age-related diseases remain major causes of morbidity and mortality worldwide. N6-methyladenosine (m6A) is a prevalent internal modification of eukaryotic mRNA that regulates RNA splicing, export, stability, translation, and decay. In this comprehensive narrative...

Yu-Ting Meng, Tian-Xing Liu, Ming-Hui Ru et al. · 0 citations
Review Aug 2026

RNA modifications as determinants of cancer cell death: from epitranscriptomic mechanisms to therapeutic targeting

It is argued that while epitranscriptomics represents a compelling regulatory axis in cancer cell death, advancing the field will require integrative, high-resolution, and functionally precise approaches to move beyond correlative frameworks toward mechanistic and clinically actionable insights.

A. Mukherjee, Ankit Kumar Bharti, D. Mathew et al. · 0 citations
Review Open access Aug 2026

m6A RNA methylation in breast cancer: from epitranscriptomic regulation to therapeutic targeting.

This review systematically summarize the functional roles of m6A regulators, including writers, erasers, and readers, in breast cancer biology and highlights the emerging clinical potential of m6A regulators as diagnostic and prognostic biomarkers, as well as therapeutic targets for overcoming drug resistance.

Zilong Chen, Chi Zhou, Zhuo-Run Song et al. · 0 citations
Review Open access Sep 2026

RNA m6A modification-regulated ferroptosis in cancer: mechanism and therapeutic potential

Empirical evidence elucidating how m6A regulators remodel cystine import, GPX4-dependent antioxidant defense, FSP1 signaling, lipid metabolism, iron handling, autophagy and tumor-microenvironmental communication is synthesized.

Qing-Miao Shi, Yang-Ni Li, Chao Guan · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.